TNF-α inhibitors used as steroid-sparing maintenance monotherapy in parenchymal CNS sarcoidosis

OBJECTIVE: To assess the efficacy of tumour necrosis factor-α (TNF-α) inhibitors used as steroid-sparing monotherapy in central nervous system (CNS) parenchymal sarcoidosis. METHODS: The French Multiple Sclerosis and Neuroinflammation Centers retrospectively identified patients with definite or prob...

Descripción completa

Detalles Bibliográficos
Autores principales: Hilezian, Frédéric, Maarouf, Adil, Boutiere, Clemence, Rico, Audrey, Demortiere, Sarah, Kerschen, Philippe, Sene, Thomas, Bensa-Koscher, Caroline, Giannesini, Claire, Capron, Jean, Mekinian, Arsene, Camdessanché, Jean-Philippe, Androdias, Géraldine, Marignier, Romain, Collongues, Nicolas, Casez, Olivier, Coclitu, Catalina, Vaillant, Mathieu, Mathey, Guillaume, Ciron, Jonathan, Pelletier, Jean, Audoin, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Neuro-Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292597/
https://www.ncbi.nlm.nih.gov/pubmed/34103339
http://dx.doi.org/10.1136/jnnp-2020-325665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292597/
https://www.ncbi.nlm.nih.gov/pubmed/34103339
http://dx.doi.org/10.1136/jnnp-2020-325665

Ejemplares similares